NCT04197037View on ClinicalTrials.gov

Prevalence of Sialorrhea in Patients Treated With Clozapine

CompletedOBSERVATIONAL
Enrollment

129

Participants

Timeline

Start Date

March 20, 2018

Primary Completion Date

March 30, 2020

Study Completion Date

December 31, 2021

Conditions
SialorrheaClozapine Adverse ReactionQuality of Life
Interventions
PROCEDURE

Evaluation of sialorrhea through questionnaires that measure daytime and nighttime sialorrhea and the impact on quality of life.

Sialorrhea will be evaluated by the Nocturnal hypersalivation rating scale (NHRS) and Drooling Severity and Frequency Scale (DSFS)

Trial Locations (1)

08019

Centre Forum Parc de Salut Mar, Barcelona

All Listed Sponsors
lead

Parc de Salut Mar

OTHER

NCT04197037 - Prevalence of Sialorrhea in Patients Treated With Clozapine | Biotech Hunter | Biotech Hunter